Mona Shahriari

Join Dr. Mona Shahriari, an Associate Clinical Professor of Dermatology at Yale University and co-founder of Central Connecticut Dermatology, as she reveals the latest breakthroughs from the 2025 AAD Annual Meeting. She discusses head-to-head trials comparing IL-17 and IL-23 inhibitors and emphasizes the importance of personalized therapy for psoriasis. Dr. Shahriari also highlights innovations in treating challenging areas like the scalp and nails, the role of GLP-1 medications, and how early intervention can significantly impact patient outcomes.